1. Home
  2. SDST vs GNTA Comparison

SDST vs GNTA Comparison

Compare SDST & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stardust Power Inc. Common Stock

SDST

Stardust Power Inc. Common Stock

HOLD

Current Price

$3.49

Market Cap

44.9M

Sector

Finance

ML Signal

HOLD

Logo Genenta Science S.p.A.

GNTA

Genenta Science S.p.A.

HOLD

Current Price

$1.89

Market Cap

39.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDST
GNTA
Founded
2022
2014
Country
United States
Italy
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.9M
39.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SDST
GNTA
Price
$3.49
$1.89
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
113.6K
111.6K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$1.35
52 Week High
$70.25
$10.00

Technical Indicators

Market Signals
Indicator
SDST
GNTA
Relative Strength Index (RSI) 46.96 40.49
Support Level $3.06 $1.80
Resistance Level $3.74 $2.20
Average True Range (ATR) 0.32 0.24
MACD 0.01 0.04
Stochastic Oscillator 53.57 59.77

Price Performance

Historical Comparison
SDST
GNTA

About SDST Stardust Power Inc. Common Stock

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

About GNTA Genenta Science S.p.A.

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Share on Social Networks: